Phosphorylated C/EBPβ Influences a Complex Network Involving YY1 and USF2 in Lung Epithelial Cells

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Viart, Victoria ^a,b   Varilh, Jessica ^b,c   Lopez, Estelle ^a,b   René, Céline ^a,b,c   Claustres, Mireille ^a,b,c   Taulan Cadars, Magali ^a,b  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; TRANSCRIPTION FACTOR YY1; UPSTREAM STIMULATORY FACTOR 2;

ARTICLE; BINDING COMPETITION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; DNA BINDING MOTIF; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MOLECULAR INTERACTION; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UPSTREAM STIMULATORY FACTORS; YY1 TRANSCRIPTION FACTOR;

EID: 84875664800     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060211     Document Type: Article

References (39)

1. Lekstrom-Himes J, Xanthopoulos KG, (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273: 28545-28548.
2. Ramji DP, Foka P, (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575.
3. Cassel TN, Nord M, (2003) C/EBP transcription factors in the lung epithelium. Am J Physiol Lung Cell Mol Physiol 285: L773-781.
4. Martis PC, Whitsett JA, Xu Y, Perl AK, Wan H, et al. (2006) C/EBPalpha is required for lung maturation at birth. Development 133: 1155-1164.
5. Pittman N, Shue G, LeLeiko NS, Walsh MJ, (1995) Transcription of cystic fibrosis transmembrane conductance regulator requires a CCAAT-like element for both basal and cAMP-mediated regulation. J Biol Chem 270: 28848-28857.
6. Matthews RP, McKnight GS, (1996) Characterization of the cAMP response element of the cystic fibrosis transmembrane conductance regulator gene promoter. J Biol Chem 271: 31869-31877.
7. Li S, Moy L, Pittman N, Shue G, Aufiero B, et al. (1999) Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation. J Biol Chem 274: 7803-7815.
8. Nuthall HN, Moulin DS, Huxley C, Harris A, (1999) Analysis of DNase-I-hypersensitive sites at the 3′ end of the cystic fibrosis transmembrane conductance regulator gene (CFTR). Biochem J 341 (Pt 3): 601-611.
9. Rene C, Taulan M, Iral F, Doudement J, L'Honore A, et al. (2005) Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway. Nucleic Acids Res 33: 5271-5290.
10. Taulan M, Lopez E, Guittard C, Rene C, Baux D, et al. (2007) First functional polymorphism in CFTR promoter that results in decreased transcriptional activity and Sp1/USF binding. Biochem Biophys Res Commun 361: 775-781.
11. Romey MC, Pallares-Ruiz N, Mange A, Mettling C, Peytavi R, et al. (2000) A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression. J Biol Chem 275: 3561-3567.
12. Chou JL, Rozmahel R, Tsui LC, (1991) Characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene. J Biol Chem 266: 24471-24476.
13. Piwien Pilipuk G, Galigniana MD, Schwartz J, (2003) Subnuclear localization of C/EBP beta is regulated by growth hormone and dependent on MAPK. J Biol Chem 278: 35668-35677.
14. Descombes P, Schibler U, (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569-579.
15. Calkhoven CF, Muller C, Leutz A, (2000) Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev 14: 1920-1932.
16. Crawford EL, Blomquist T, Mullins DN, Yoon Y, Hernandez DR, et al. (2007) CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions. Carcinogenesis 28: 2552-2559.
17. Ayoubi TAY, Meulemans SMP, Van de Ven WJM (2007) Upstream Stimulatory Factor (USF) and CCAAT/Enhancer Binding Protein δ (C/EBPδ) Compete for overlapping Sites in the Negative Regulatory Region of the HIV-1 LTR. Nature Precedings: doi: 10.1038.
18. Bauknecht T, See RH, Shi Y, (1996) A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J Virol 70: 7695-7705.
19. Metz R, Ziff E, (1991) cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes Dev 5: 1754-1766.
20. Lane MD, Tang QQ, Jiang MS, (1999) Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem Biophys Res Commun 266: 677-683.
21. Berg T, Didon L, Barton J, Andersson O, Nord M, (2005) Glucocorticoids increase C/EBPbeta activity in the lung epithelium via phosphorylation. Biochem Biophys Res Commun 334: 638-645.
22. Kowenz-Leutz E, Twamley G, Ansieau S, Leutz A, (1994) Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression. Genes Dev 8: 2781-2791.
23. Vinson C, Myakishev M, Acharya A, Mir AA, Moll JR, et al. (2002) Classification of human B-ZIP proteins based on dimerization properties. Mol Cell Biol 22: 6321-6335.
24. Kim JW, Tang QQ, Li X, Lane MD, (2007) Effect of phosphorylation and S-S bond-induced dimerization on DNA binding and transcriptional activation by C/EBPbeta. Proc Natl Acad Sci U S A 104: 1800-1804.
25. Roos AB, Tove B, Barton JL, Didon L, Nord M, (2012) Airway Epithelial Cell Differentiation During Lung Organogenesis Requires C/EBPa and C/EBPb. Developmental Dynamics 241: 911-923.
26. Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, et al. (2003) Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 278: 7674-7682.
27. Matlapudi A, Wang M, Rosenberg E, Ewing JR, Feinstein SI, (2002) A role for C/EBP delta in human surfactant protein A (SP-A) gene expression. Biochim Biophys Acta 1575: 91-98.
28. Rene C, Lopez E, Claustres M, Taulan M, Romey-Chatelain MC, (2010) NF-E2-related factor 2, a key inducer of antioxidant defenses, negatively regulates the CFTR transcription. Cell Mol Life Sci 67: 2297-2309.
29. Roesler WJ, (2001) The role of C/EBP in nutrient and hormonal regulation of gene expression. Annu Rev Nutr 21: 141-165.
30. Lee JS, Galvin KM, See RH, Eckner R, Livingston D, et al. (1995) Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev 9: 1188-1198.
31. Dahle MK, Tasken K, Tasken KA, (2002) USF2 inhibits C/EBP-mediated transcriptional regulation of the RIIbeta subunit of cAMP-dependent protein kinase. BMC Mol Biol 3: 10.
32. Baudouin-Legros M, Hamdaoui N, Borot F, Fritsch J, Ollero M, et al. (2008) Control of basal CFTR gene expression by bicarbonate-sensitive adenylyl cyclase in human pulmonary cells. Cell Physiol Biochem 21: 75-86.
33. Farmen SL, Karp PH, Ng P, Palmer DJ, Koehler DR, et al. (2005) Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. Am J Physiol Lung Cell Mol Physiol 289: L1123-1130.
34. Shi W, Bellusci S, Warburton D, (2007) Lung development and adult lung diseases. Chest 132: 651-656.
35. Gordon S, Akopyan G, Garban H, Bonavida B, (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25: 1125-1142.
36. Dhar M, Taneja R, (2001) Cross-regulatory interaction between Stra13 and USF results in functional antagonism. Oncogene 20: 4750-4756.
37. Kouzarides T, (2000) Acetylation: a regulatory modification to rival phosphorylation? Embo J 19: 1176-1179.
38. Schwartz C, Beck K, Mink S, Schmolke M, Budde B, et al. (2003) Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity. Embo J 22: 882-892.
39. Hernandez-Hernandez A, Ray P, Litos G, Ciro M, Ottolenghi S, et al. (2006) Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1. Embo J 25: 3264-3274.